Zhen Xu

2.1k total citations · 1 hit paper
34 papers, 785 citations indexed

About

Zhen Xu is a scholar working on Molecular Biology, Genetics and Hematology. According to data from OpenAlex, Zhen Xu has authored 34 papers receiving a total of 785 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 7 papers in Genetics and 6 papers in Hematology. Recurrent topics in Zhen Xu's work include Epigenetics and DNA Methylation (7 papers), Chronic Lymphocytic Leukemia Research (3 papers) and Multiple Myeloma Research and Treatments (3 papers). Zhen Xu is often cited by papers focused on Epigenetics and DNA Methylation (7 papers), Chronic Lymphocytic Leukemia Research (3 papers) and Multiple Myeloma Research and Treatments (3 papers). Zhen Xu collaborates with scholars based in China, Australia and United States. Zhen Xu's co-authors include David C.S. Huang, Jianan Gong, Ian J. Majewski, Andrew W. Roberts, Peter E. Czabotar, Rachel Thijssen, Christoffer Flensburg, David Westerman, Piers Blombery and Richard W. Birkinshaw and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Blood.

In The Last Decade

Zhen Xu

33 papers receiving 777 citations

Hit Papers

Acquisition of the Recurrent Gly101Val Mutation in BCL2 C... 2018 2026 2020 2023 2018 50 100 150 200 250

Peers

Zhen Xu
Jeffrey R. Shearstone United States
Yujie Wu China
Sonja Eberth Germany
Megan M. O’Meara United States
Sanjai Sharma United States
Paul Glover United States
Hind Medyouf Germany
Jeffrey R. Shearstone United States
Zhen Xu
Citations per year, relative to Zhen Xu Zhen Xu (= 1×) peers Jeffrey R. Shearstone

Countries citing papers authored by Zhen Xu

Since Specialization
Citations

This map shows the geographic impact of Zhen Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhen Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhen Xu more than expected).

Fields of papers citing papers by Zhen Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhen Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhen Xu. The network helps show where Zhen Xu may publish in the future.

Co-authorship network of co-authors of Zhen Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Zhen Xu. A scholar is included among the top collaborators of Zhen Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhen Xu. Zhen Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zong, Ming, Zhen Xu, Qiunong Guan, et al.. (2025). Single-cell transcriptomic analysis of interactions of peritoneal mesenchymal stem cells with macrophages in prevention of peritoneal membrane injury. Biochemical and Biophysical Research Communications. 781. 152491–152491.
2.
Zhang, Li, Weibin Li, Zhen Xu, et al.. (2025). Promoting transcellular traversal of the blood–brain barrier by simultaneously improving cellular uptake and accelerating lysosomal escape. Nanoscale. 17(11). 6780–6792. 2 indexed citations
3.
Wang, Yuting, Xiaoran Wang, Miaomiao Niu, et al.. (2024). Discovery of a Novel and Potent Dual-Targeting Inhibitor of ATM and HDAC2 Through Structure-Based Virtual Screening for the Treatment of Testicular Cancer. Drug Design Development and Therapy. Volume 18. 5283–5297. 1 indexed citations
4.
Behrens, Kira, Natalie Brajanovski, Zhen Xu, et al.. (2024). ERG and c-MYC regulate a critical gene network in BCR::ABL1-driven B cell acute lymphoblastic leukemia. Science Advances. 10(10). eadj8803–eadj8803. 6 indexed citations
5.
Xu, Zhen, Christoffer Flensburg, Rebecca A. Bilardi, & Ian J. Majewski. (2023). Uridine–cytidine kinase 2 potentiates the mutagenic influence of the antiviral β-d-N4-hydroxycytidine. Nucleic Acids Research. 51(22). 12031–12042. 5 indexed citations
6.
Li, Yueyuan, Qing Liu, Ping Wang, et al.. (2023). An Electrochemical Immunosensor for Sensitive Detection of Cardiac Troponin I Based on the Amplification Effect of Asymmetric Bowl-Shaped Mesoporous Nanospheres. Journal of The Electrochemical Society. 170(7). 77508–77508. 1 indexed citations
7.
Zhang, Jingfang, Peng Jiang, Lin Wang, et al.. (2023). Identification of SLC2A3 as a prognostic indicator correlated with the NF-κB/EMT axis and immune response in head and neck squamous cell carcinoma. Channels. 17(1). 2208928–2208928. 7 indexed citations
8.
Xu, Zhen, Qiong Wang, Tao Wang, et al.. (2023). Dual Function of CCAT2 in Regulating Luminal Subtype of Breast Cancer Depending on the Subcellular Distribution. Cancers. 15(2). 538–538. 1 indexed citations
9.
Li, Xuejun, X. Sun, Jing Pang, et al.. (2022). Breast microbiome associations with breast tumor characteristics and neoadjuvant chemotherapy: A case-control study. Frontiers in Oncology. 12. 926920–926920. 10 indexed citations
10.
Xu, Zhen, et al.. (2022). Inversion Effect of Hand Postures: Effect of Visual Experience Over Long and Short Term. i-Perception. 13(3). 1243886839–1243886839. 1 indexed citations
11.
Xu, Zhen, Cassandra J. Vandenberg, Elizabeth Lieschke, et al.. (2021). CHK2 Inhibition Provides a Strategy to Suppress Hematologic Toxicity from PARP Inhibitors. Molecular Cancer Research. 19(8). 1350–1360. 11 indexed citations
12.
Zhen, Lixiao, Qian Zhao, Jinhui Lü, et al.. (2020). miR-301a-PTEN-AKT Signaling Induces Cardiomyocyte Proliferation and Promotes Cardiac Repair Post-MI. Molecular Therapy — Nucleic Acids. 22. 251–262. 29 indexed citations
13.
14.
Blombery, Piers, Mary Ann Anderson, Jianan Gong, et al.. (2018). Acquisition of the Recurrent Gly101Val Mutation in BCL2 Confers Resistance to Venetoclax in Patients with Progressive Chronic Lymphocytic Leukemia. Cancer Discovery. 9(3). 342–353. 276 indexed citations breakdown →
15.
Anstee, Natasha S., Rebecca A. Bilardi, Ashley P. Ng, et al.. (2018). Impact of elevated anti-apoptotic MCL-1 and BCL-2 on the development and treatment of MLL-AF9 AML in mice. Cell Death and Differentiation. 26(7). 1316–1331. 35 indexed citations
16.
Xu, Zhen, Phillip P. Sharp, Yuan Yao, et al.. (2016). BET inhibition represses miR17-92 to drive BIM-initiated apoptosis of normal and transformed hematopoietic cells. Leukemia. 30(7). 1531–1541. 25 indexed citations
17.
Zhan, Yifan, Priscilla Soo, Zhen Xu, et al.. (2016). Plasmacytoid dendritic cells are short-lived: reappraising the influence of migration, genetic factors and activation on estimation of lifespan. Scientific Reports. 6(1). 25060–25060. 43 indexed citations
18.
Xu, Zhen, Xinxing Gao, Yinghong He, et al.. (2012). Synergistic Effect of SRY and Its Direct Target, WDR5, on Sox9 Expression. PLoS ONE. 7(4). e34327–e34327. 24 indexed citations
19.
Xu, Zhen, et al.. (2012). Interactions of Hydroxyapatite with Proteins and Its Toxicological Effect to Zebrafish Embryos Development. PLoS ONE. 7(4). e32818–e32818. 41 indexed citations
20.
Xu, Zhen, Yinghong He, Junyi Ju, et al.. (2012). The role of WDR5 in silencing human fetal globin gene expression. Haematologica. 97(11). 1632–1640. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026